Thailand officially enters dry season today

Thailand has officially entered the dry season, starting today (Saturday), which will last until mid-May, according to the Meteorological Department. It said that the northeastern monsoon wind, which had been blowing through northern Thailand, has been replaced by the warm southeastern wind, signaling the arrival of summer. Temperatures during the dry season are forecast to […]

Continue Reading

Supporting Government’s Policy of Economic Recovery in the Post COVID-19 Era

Thai Ambassadors and Consuls-General in the Middle East and North Africa have discussed ways to support the Royal Thai Government’s policy of economic recovery and development in the post COVID-19 era.   The Ministry of Foreign Affairs conducted a virtual meeting with Thai Ambassadors and Consuls-General in the Middle East and North Africa on 24-25 […]

Continue Reading

Promoting Integrity and Transparency in the Business Sector to Curb Corruption

orruption exists in both public and private sectors. In a move to promote the anti-corruption drive in the private sector, the Office of the National Anti-Corruption Commission (NACC), during its recent meeting, approved guidelines to promote integrity and transparency in private companies that are partners in contracts with the public sector.   The meeting also […]

Continue Reading

CNH Industrial N.V. announces the extension by one additional year to March 2026 of its syndicated credit facility

London, February 26, 2021 CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) announces that it has exercised the second one-year extension option (i.e. to March 2026) of its syndicated committed revolving credit facility for € 3.9505 billion. The remaining € 49.5 million will mature in March 2025. CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) is a […]

Continue Reading

U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy

SHANGHAI, China, Feb. 27, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the U.S. government has agreed to purchase a minimum of 100,000 doses of etesevimab (JS016 or LY-CoV016) 1400 mg and bamlanivimab (LY-CoV555) 700 […]

Continue Reading